Georgia’s medical cannabis program is expanding even as state regulators wait for input from the DEA. Here’s why it matters and what DMV readers should watch.

Blackwell Captive teams with Apta Health to add a guided cash‑pay option for employers in its programs, including Humboldt Health, aiming to simplify access and cost control.

A new DEA registration pathway pulls state-licensed medical cannabis manufacturers, distributors, and labs into the federal Schedule III framework—potentially easing 280E tax pain.

A Texas case profiled by High Times shows how extreme cannabis penalties still happen. Here’s what DMV readers should consider about risk, compliance and delivery rules.

A rare insurance-coverage clash in cannabis could ripple through delivery operators’ risk plans. Here’s what DMV consumers and couriers should watch now.

US Eagle Federal Credit Union will shut its cannabis banking arm on Nov. 1, citing competition, per MJBizDaily. Here’s what it signals for operators—and DMV delivery teams watching compliance closely.

A $2,500 settlement over about 200 plants shows how fast compliance gaps become costly. Here’s what DMV operators, delivery builders, and investors should learn now.

Major carriers want clear federal protections to serve state-legal cannabis businesses. Here’s why that matters for delivery, couriers, and DMV operators.

A cannabis-only group captive for employer health plans aims to cut overhead, increase cost control, and protect margins for delivery operators and dispensaries in the DMV and beyond.

Index inclusion can boost visibility, liquidity, and capital access. Here’s how it may ripple across marijuana delivery stocks, cannabis apps, and DMV entrepreneurs.

S&P added Trulieve to its Total Market and Completion indices. Here’s what that could mean for investors, delivery operators, and the DMV’s cannabis economy.

MJBizDaily reports Cresco paid $50M for nine Pennsylvania MMJ stores, becoming the state’s No. 1 retailer and wholesaler. Here’s how that scale-up touches delivery models, DMV opportunities, and investment risk.

A Sixth Circuit ruling says federal illegality blocks enforcement of a Michigan cannabis supply deal. Here’s how that risk touches delivery contracts in DC, Maryland, and Virginia.

A short federal reprieve isn’t stopping distributors, retailers, and delivery operators from unwinding hemp deals. Here’s how DMV businesses can stay compliant.

Psychedelic Alpha reports the FDA held a public hearing on psychedelics. Here’s what that means, what’s unknown, and how DC, Maryland and Virginia should watch the next steps.

Curaleaf’s hostile push for Aurora isn’t just about a headline premium. It spotlights cash, debt, and market position — and how consolidation could reshape delivery.

Operational change is the earliest safety-and-cost signal in cannabis logistics. Here’s how delivery operators and investors can turn risk awareness into business edge.

MJBizDaily reports Endovia is seeking FDA veterinary approval for a cannabinoid drug aimed at canine cancer and chronic pain—an R&D path that could reshape investor focus.

New Cannabis Ventures reports Vireo is getting bigger but dropping to new lows. Here’s how to read that headline through a delivery laws and compliance lens in the DMV.

HRSA logged 59 comments on training and outpatient delivery models for potential FDA‑approved psychedelic therapies. We unpack what’s being explored, plus why credentials, clinics, and costs matter.